Islam M. Zaydan

Differential tractography as a track-based biomarker for neuronal injury

R. Mark Richardson, Fang-Cheng Yeh, Joseph C. Maroon, 2019, NeuroImage.

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

Jeffrey A. Cohen, Islam M. Zaydan, Gregory F. Wu, 2022, The Lancet Neurology.

Psychometric Properties of a Core Set of Measures of Balance for People With Cerebellar Ataxia Secondary to Multiple Sclerosis.

Islam M. Zaydan, J. Mottershead, B. Klatt, 2017, Archives of physical medicine and rehabilitation.